Rhinitis – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Tue, 02 Jun 2026 04:15:11 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Rhinitis – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study of Actisoufre nasal spray containing sodium sulfide and saccharomyces extract for adults and children over 6 years with acute rhinitis, rhinopharyngitis, and rhinosinusitis https://clinicaltrials.eu/trial/study-of-actisoufre-nasal-spray-containing-sodium-sulfide-and-saccharomyces-extract-for-adults-and-children-over-6-years-with-acute-rhinitis-rhinopharyngitis-and-rhinosinusitis/ Wed, 29 Apr 2026 15:06:23 +0000 https://clinicaltrials.eu/trial/study-of-actisoufre-nasal-spray-containing-sodium-sulfide-and-saccharomyces-extract-for-adults-and-children-over-6-years-with-acute-rhinitis-rhinopharyngitis-and-rhinosinusitis/ This study examines the effectiveness of Actisoufre nasal spray in treating acute rhinitis (inflammation of the nasal passages), rhinopharyngitis (inflammation of the nose and throat area), and rhinosinusitis (inflammation of the nose and sinuses) that do not require antibiotic treatment. The study will test whether the nasal spray containing sodium sulfide nonahydrate and Saccharomyces cerevisiae extract can help reduce symptoms like nasal congestion, runny nose, and thick mucus.

The purpose of this research is to evaluate how well Actisoufre nasal spray works compared to placebo when used three times daily in each nostril for seven days. The study involves both adults and children over 6 years old who have developed sudden symptoms of nose and throat inflammation within the previous 48 hours.

During the study, participants will use either Actisoufre nasal spray or placebo. They will need to report their symptoms, including how well they sleep and their overall quality of life. The researchers will track any changes in symptoms, particularly focusing on improvements in nasal congestion, runny nose, and other related symptoms over the course of treatment.

]]> Study of Mometasone Nasal Spray Treatment for Patients with Rhinitis Medicamentosa (Nasal Decongestant Dependency) https://clinicaltrials.eu/trial/study-on-reducing-nasal-spray-overuse-in-patients-with-rhinitis-medicamentosa-using-mometasone-and-motivational-support/ Wed, 29 Apr 2026 15:05:21 +0000 https://clinicaltrials.eu/trial/study-on-reducing-nasal-spray-overuse-in-patients-with-rhinitis-medicamentosa-using-mometasone-and-motivational-support/ This study focuses on rhinitis medicamentosa, a condition where the nose becomes congested due to overuse of nasal decongestant sprays. The research aims to evaluate the effectiveness of a treatment plan that helps patients stop using nasal decongestants through a combination of mometasone furoate nasal spray and supportive counseling.

The treatment involves using mometasone furoate, a type of steroid nasal spray, as part of a structured plan to help patients reduce and eventually stop their dependence on decongestant nasal sprays. The study will monitor patients for 12 weeks during the treatment phase and continue following up with them to check if they maintain their progress.

Throughout the study, patients will be asked to keep track of their nasal symptoms and breathing ability. The study will measure how well patients can breathe through their nose, assess their quality of sleep, and examine the inside of their nose to monitor any changes. The research team will also evaluate how many patients successfully stop using decongestant sprays and whether they maintain this improvement over time.

]]>